Praxis Precision Medicine (PRAX) Stock Price, Quote, News & History | Benzinga

Praxis Precision Medicines Inc (PRAX) Stock Price, Quote, News & History

PRAXNASDAQ

Trade with Public

Trade with Public

$367.85

-9.52-2.52%

At close: Aug 27, 5:00 PM EST

$367.85

N/A

After Hours: 4:00 PM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Stock Report

Key Statistics

Open

$375.77

Close

$367.85

Volume / Avg.

242.88K / 497.57K

Day Range

$366.88 - $377.50

52 Wk Range

37.19 - 392.70

Market Cap

$10.27B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

52

Short Interest

13.34%

Days to Cover

7.79

Recent Praxis Precision Medicines, Inc. News

Motorola Solutions Posts Upbeat Q2 Earnings, Joins Insmed, Diodes, Parker-Hannifin And Other Big Stocks Moving Higher On Thursday

US stocks mixed on Thurs. Dow Jones down 50 pts. Motorola Solutions Inc shares up 9.5% after reporting strong Q2 results & raised guidance.

Avi Kapoor

Applied Materials To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Monday

Top Wall Street analysts upgraded and downgraded several top companies, including Applied Materials, Robinhood, Liquidia, Airbnb, Praxis, Alnylam, and Uniqure.

Avi Kapoor

Praxis' Seizure Drug Move Towards Faster Development After Positive Trial Results

FDA grants Breakthrough Therapy Designation to Praxis' elsunersen after strong seizure reduction data in SCN2A-DEE.

Vandana Singh

CrowdStrike To Gain 7%? Here Are 10 Top Analyst Forecasts For Tuesday

Wall Street analysts change ratings for top stocks: CRWD price target raised, FULC target lowered, HPQ target raised, PRAX target cut, GNSS target raised, INTU target lowered, GH target raised, CRDO target raised, PRAX target lowered, NU target cut.

Avi Kapoor

Praxis Reassesses Vormatrigine Program After Pivotal Epilepsy Study Misses Primary Endpoint

Praxis Precision Medicines reports mixed Phase 2/3 POWER1 results for vormatrigine, with higher-dose data showing stronger seizure reduction.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-305.08M

Investing Cash Flow (TTM)

-611.27M

Financing Cash Flow (TTM)

1.23B

Free Cash Flow (TTM)

-306.16M

Capital Expenditure (TTM)

-1.08M

Net Change in Cash (TTM)

316.93M

Analyst Trends and Forecast

3

Apr

4

1

May

8

1

Jun

2

Jul

3

1

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.8

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$9.50B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

7.65

Earnings Yield % (TTM)

-3.53%

Earnings Yield % (FWD)

-3.85%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$48.03

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$474.76M

Debt to Equity

0.00

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$375.77

Close

$367.85

Volume / Avg.

242.88K / 497.57K

Day Range

$366.88 - $377.50

52 Wk Range

37.19 - 392.70

Market Cap

$10.27B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

52

Short Interest

13.34%

Days to Cover

7.79

About

Sector

Health Care

Industry

Biotechnology

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excita...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Praxis Precision Medicine (PRAX) stock?

A

You can purchase shares of Praxis Precision Medicine (NASDAQ:PRAX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Praxis Precision Medicine (PRAX) competitors?

A

Other companies in Praxis Precision Medicine’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Praxis Precision Medicine (PRAX) stock?

A

Praxis Precision Medicine has a consensus price target of $538.65.

Q

What is the current price for Praxis Precision Medicine (PRAX)?

A

The stock price for Praxis Precision Medicine (NASDAQ: PRAX) is $367.85 last updated August 27, 2026 at 4:00 PM EDT.

Q

Does Praxis Precision Medicine (PRAX) pay a dividend?

A

There are no upcoming dividends for Praxis Precision Medicine.

Q

When is Praxis Precision Medicine (NASDAQ:PRAX) reporting earnings?

A

Praxis Precision Medicine does not have any upcoming earnings scheduled.

Q

Is Praxis Precision Medicine (PRAX) going to split?

A

There is no upcoming split for Praxis Precision Medicine.

Q

What sector and industry does Praxis Precision Medicine (PRAX) operate in?

A

Praxis Precision Medicine is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.